Compare · CPUH vs SAGA
CPUH vs SAGA
Side-by-side comparison of Compute Health Acquisition Corp. (CPUH) and Sagaliam Acquisition Corp. (SAGA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CPUH and SAGA operate in Blank Checks (Finance), so they compete in similar markets.
- CPUH carries a market cap of $1.05B.
Compute Health Acquisition Corp.
Compute Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Wilmington, Delaware.
Sagaliam Acquisition Corp.
Sagaliam Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the telecommunications, media, and technology industries. The company was incorporated in 2021 and is based in Los Angeles, California.
Latest CPUH
- SEC Form 15-12G filed by Compute Health Acquisition Corp.
- SEC Form 4: Compute Health Sponsor Llc was granted 2,088,327 shares and returned 2,088,327 shares to the company (Amendment)
- SEC Form 4: Harsh Michael was granted 21,120 shares and returned 31,120 shares to the company, closing all direct ownership in the company
- SEC Form 4: Watanabe Gwendolyn A was granted 21,120 shares and returned 21,120 shares to the company
- SEC Form 25-NSE filed by Compute Health Acquisition Corp.
- Allurion Debuts as a Publicly Traded Company on the NYSE
- SEC Form DEFA14A filed by Compute Health Acquisition Corp.
- Compute Health Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion
- SEC Form 425 filed by Compute Health Acquisition Corp.
Latest SAGA
- Sagaliam Acquisition Corp Launches Improved IPF Formula with Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical
- Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.
- SEC Form 25-NSE filed by Sagaliam Acquisition Corp.
- Sagaliam Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits
- Sagaliam Acquisition To Delist From Nasdaq On March 6
- SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ
- SEC Form 10-Q filed by Sagaliam Acquisition Corp.
- SEC Form SC 13G/A filed by Sagaliam Acquisition Corp. (Amendment)
- SEC Form SC 13G filed by Sagaliam Acquisition Corp.
- SEC Form 10-Q filed by Sagaliam Acquisition Corp.